Foot and Ankle Allograft Market Analysis and Forecast Report Till 2030

foot and ankle allograft

The foot and ankle allograft market size is expected to reach USD 211.19 Million in 2030 and register a revenue CAGR of 6.6% over the forecast period, according to latest report by Reports and Data. Continuous product commercialization and rise in public-private educational and awareness initiatives related to preventive and post-operative care are some major factors driving foot and ankle allograft market revenue growth.

Paragon 28, a US-based foot and ankle surgical product manufacturer has introduced the Preserve HammerGraft System for hammer toe and novel charcot and midfoot reconstruction, as well as the Gorilla Medial Column Arch Plating System for medial column abnormalities. The new hammergraft system complements company’s existing Preserve range of aseptically treated implants that are free of gamma radiation and bleaching. Four allograft implants in 2.3 mm and 2.8 mm straight and angled alternatives are included in the system, which are obtained from the cortical rim of the tibia or femur, to give equivalent density to the PIP joint along with strength and to meet blood flow requirements of the region. Launch of such new advanced products is expected to have a major impact on revenue growth of the foot and ankle allograft market.

Increasing incidence of fractures across the globe is a major factor driving revenue growth of the foot and ankle allograft market. A study conducted by the National Electronic Injury Surveillance System identified all individuals with ankle fractures who visited emergency rooms in the United States, while Census data was used to establish the incidence rates of ankle fractures by age, gender, and race. 673,214 ankle fractures were estimated to occur during 2012 to 2016, with an incidence rate of 4.22/10,000 person-years. The average age of patients with ankle fractures was 37 ± 22.86 (SD) years, with 23.5% (7.56/10,000 person-years) of ankle fractures occurring in patients aged 10 to 19 years. Furthermore, men accounted for 44% of ankle fractures (3.81/10,000 person-years), while women accounted for 56% (4.63/10,000 person-years).

For 71 % of the subjects, race/ethnicity information was available, with incidence rates of 2.85 per 10,000 person-years for whites, 3.01 per 10,000 person-years for blacks, and 4.08 per 10,000 person-years for others. It was found that falls were the most prevalent cause of injury (54.83%), followed by sports (20.76%), exercise (16.84%), jumping (4.42%), trauma (2.84%), and other causes (0.30 %). Ankle fractures were most common in men between the ages of 10 and 19 years, although women were more typically injured in all other age categories. High incidence of ankle fractures is expected to provide a major boost to the market. However, the high cost of operation, as well as complications associated with procedures and clinical constraints, are limiting growth of the market.

For More Industry Insight, Request Sample@ https://www.reportsanddata.com/download-summary-form/4972

Some Key Highlights From the Report

  • In July 2021, RTI Surgical, a leading surgical implant company providing blue-chip OEM customers with a portfolio of tissue-based, synthetic, and metal implants, entered into a long-term strategic agreement with leading global medical device OEM Exactech, related to the development and supply of biologic bone substitutes.
  • Orthopedic reconstruction segment is expected to account for largest revenue share in the foot and ankle allograft market over the forecast period. Rising incidence of osteoarthritis and rheumatoid arthritis around the world, as well as technological advancements in the orthopedic joint reconstruction field, are boosting revenue growth of this segment.
  • Development of free-form biomaterials/scaffolds for tissue regeneration is now possible due to new manufacturing methods, such as fast prototyping or Three Dimensional (3D) printing. This printing technology can create materials with computer-aided architecture, additives of inorganic/organic composition, and connective pores. Biomaterials that could be used in 3D printing, such as collagen and gelatin, are also considered for this purpose. 3D printing is used in a variety of medical applications, and such procedures have undoubtedly paved the way for bone tissue engineering and regeneration, as well as individualized medicine in clinical orthopedic and orthodontic operations.

Purchase Research Report@ https://www.reportsanddata.com/report-pricing/4972

  • Porous bone implants, prosthetics, wearable biosensors, and drug delivery devices are examples of bioimplants used in medical or therapeutic applications. They are normally implanted for a duration of more than 30 days in the human body. They integrate the human body, material qualities, and bioimplant intactness to fix, support, recreate, or improve the functions of human tissues. Demand for bioimplants is surging due to increasing aging population and scarcity of donor organs in medical treatment. Various bioimplants, such as brain/neural implants, bone/cartilage implants, dental implants, and other structural implants, have been developed by key players as a result of the study and expansion in the biomaterials field. Increasing focus on research & development is expected to drive market revenue growth during the forecast period.
  • The foot and ankle allograft market in North America is expected to account for largest revenue share over the forecast period. Increasing geriatric population and arthroscopic surgeries being performed are expected to support market revenue growth in the region during the forecast period.
  • Key players profiled in the market report include CONMED Corporation, Wright Medical Group N.V., AlloSource, Bone Bank Allografts, RTI Surgical Holdings, Inc., Zimmer Biomet, JRF Ortho, Integra Life Sciences Corporation, Smith & Nephew Plc, and DePuy Synthes, among others.

Eye Care Product Market Analysis By Product Type (Ointment, Artificial Tear Drops Etc.), Product Form (Cream, Gel, Solutions Etc.), Availability (Retail, Online And Hospital Pharmacies),And By Application (Single Purpose And Multi-Purpose), Forecasts To 2028

Breath Analyzer Market Analysis, By Technology (Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy), By Application (Drug Abuse Detection, Alcohol Detection, Medical Applications), By End Use (Law Enforcement Agencies, Enterprises, Individuals), Forecasts To 2028

Dry Powder Inhaler Device Market By Product (Capsule based, Blister based, Reservoir/Cartridge based, Others), By Applications (Asthma, COPD, Diabetes, Hereditary diseases, Other), By Type (Multi-Dose and Single Dose), By End User, Forecast to 2020-2028

In vivo CRO Market Analysis, By Type (Rodent-Based, Non-Rodent Based), by GLP Type (Non-GLP, GLP Toxicology), by Indication (Autoimmune, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, Others), Forecasts To 2028

Dental X-Ray Market by Product (Digital X-ray, Analog X-ray), by Type (Extraoral, Intraoral), by Application (Diagnostic, Therapeutic, Cosmetic, Forensic), By End-use (Dental Hospitals & Clinics, Dental Academic & Research Institutes, Forensic Laboratories), And Segment Forecasts to 2028

Deoxyribonucleic Acid (DNA) Purification Market By Type (Silica Membrane, Anion Exchange Resin, Switchable Surface Charge, Biotechnology), By Purity Process (Molecular Grade, Transfection Grade), By Application, And Segment Forecasts To 2027

Neuroleptics Market Size, Trends & Analysis, By Product (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), By Disease (Schizophrenia, Bipolar Disorder, Dementia, Unipolar Depression, Others), By End-User (Hospital, Retail, Online), By Region, Segment Forecasts To 2028

You may also like...

Leave a Reply

Your email address will not be published.